Acrivon Therapeutics (ACRV) Q3 2025 Earnings

Aug 13Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.66
-0.61
-0.56
-0.51

Details

Expected EPS
-0.567778
Actual EPS
-0.55
Surprise EPS
0.02
Surprise Percent
+3.13%

Description

⁨Acrivon Therapeutics⁩ (⁦ACRV⁩) has reported earnings of ⁦-0.55⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts